Biología de Sistemas
Departamento
Manuel Vicente
Sánchez Chapado
Profesor/a Emérito/a
Publicaciones en las que colabora con Manuel Vicente Sánchez Chapado (40)
2023
-
Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications
International Journal of Molecular Sciences, Vol. 24, Núm. 21
2022
-
A Highly Sensitive Immunoassay for Determination of Immune Response to SARS-CoV-2 in Capillary Blood Samples
Biomedicines, Vol. 10, Núm. 11
2021
-
Increase in ischemia-modified albumin and pregnancy-associated plasma protein-a in covid-19 patients
Journal of Clinical Medicine, Vol. 10, Núm. 23
2018
-
Does [-2]Pro-Prostate Specific Antigen Meet the Criteria to Justify Its Inclusion in the Clinical Decision-Making Process?
Urologia Internationalis, Vol. 100, Núm. 2, pp. 146-154
-
Validación del índice de salud prostática en un modelo predictivo de cáncer de próstata
Actas Urologicas Espanolas, Vol. 42, Núm. 1, pp. 25-32
2017
-
A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer
APMIS, Vol. 125, Núm. 9, pp. 787-796
2016
-
A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy
Urologia Internationalis, Vol. 97, Núm. 1, pp. 16-25
-
Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer
Oncotarget, Vol. 7, Núm. 32, pp. 52195-52206
-
Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile
Journal of Urology, Vol. 195, Núm. 3, pp. 619-626
-
Survival predictors in patients with prostate adenocarcinoma with hormonal blockade
Pathology Research and Practice, Vol. 212, Núm. 10, pp. 899-903
2015
-
VIP induces NF-κB1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells
Cellular Signalling, Vol. 27, Núm. 2, pp. 236-244
2014
-
A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis
Prostate, Vol. 74, Núm. 12, pp. 1171-1182
-
Prostate anatomy in motheaten viable (mev) mice with mutations in the protein tyrosine phosphatase SHP-1
Actas Urologicas Espanolas, Vol. 38, Núm. 7, pp. 438-444
-
Signalling pathways involved in antitumoral effects of VIP in human renal cell carcinoma A498 cells: VIP induction of p53 expression
International Journal of Biochemistry and Cell Biology, Vol. 53, pp. 295-301
2013
-
Antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice
Cancer Letters, Vol. 336, Núm. 1, pp. 196-203
-
The study of DNA methylation in urological cancer: Present and future
Actas Urologicas Espanolas
-
Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma
Molecular and Cellular Endocrinology, Vol. 365, Núm. 2, pp. 212-222
2012
-
Antioxidant activity of vasoactive intestinal peptide in HK2 human renal cells
Peptides, Vol. 38, Núm. 2, pp. 275-281
-
Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance
Histology and Histopathology, Vol. 27, Núm. 8, pp. 1093-1101
-
Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1823, Núm. 10, pp. 1676-1685